Kymera Therapeutics Inc
KYMR
NASDAQ
Biotechnology
$117.39
USD
+2.97 (+2.60%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $9.48B
Volume 468.5K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
CYTK | Cytokinetics Inc | $10.70B | - | -21.1% | - | |
KRYS | Krystal Biotech Inc | $9.73B | 40.29 | +22.6% | - | |
PTGX | Protagonist Therapeutics Inc | $9.56B | 115.35 | +34.8% | - | |
IONS | Ionis Pharmaceuticals Inc | $9.51B | - | -7.5% | - | |
SYRE | Spyre Therapeutics Inc | $9.29B | - | - | - | |
KYMR | Kymera Therapeutics Inc | $9.03B | - | +134.8% | - | |
PCVX | Vaxcyte Inc | $8.67B | - | - | - | |
IMVT | Immunovant Inc | $8.24B | - | - | - | |
RYTM | Rhythm Pharmaceuticals Inc | $7.91B | - | +53.5% | - | |
IBRX | Immunitybio Inc | $7.87B | - | +192.9% | - |
Top Peer by Growth
Kymera Therapeutics Inc
+134.8% YoY Revenue
Lowest P/E Ratio
Krystal Biotech Inc
40.23x P/E
Best 1-Year Return
Praxis Precision Medicines Inc
+697.2% Return